Literature DB >> 3974275

Determinants of operative mortality for patients undergoing aortic valve replacement. Discriminant analysis of 1,479 operations.

W C Scott, D C Miller, A Haverich, K Dawkins, R S Mitchell, S W Jamieson, P E Oyer, E B Stinson, J C Baldwin, N E Shumway.   

Abstract

The influence of 35 preoperative and intraoperative characteristics on operative mortality risk after 1,479 isolated aortic valve replacement procedures (1967 to 1981) was investigated utilizing univariate and multivariate logistic regression analyses. Mean age at operation was 58 +/- 13 years; 72% of patients were men. Physiology was classified as aortic stenosis (58%), regurgitation (30%), or both (9%). The overall operative mortality rate was 7% +/- 1%, but there were substantial differences in operative mortality rates among physiological subgroups (aortic regurgitation, 10% +/- 2%; aortic stenosis, 6% +/- 1%; stenosis/regurgitation, 5% +/- 2%). Independent determinants of operative mortality rate in the entire group were advanced New York Heart Association functional class, renal dysfunction, physiological subgroup, atrial fibrillation, and older age. In the aortic regurgitation subgroup, functional class, atrial fibrillation, and operative year were independent predictors. In the aortic stenosis subgroup, the significant determinants were functional class, renal dysfunction, age, prosthetic valve dysfunction, and absence of angina. Concomitant coronary bypass grafting, previous operation, endocarditis, and ascending aortic replacement had no independent predictive effect on operative mortality rate. Thus, the early results of aortic valve replacement can be related to several specific variables describing the functional and physiological status of the patient. Operative mortality rate is not independently related to previous operation or concomitant operative procedures. Specific differences in risk factors exist among the various physiological subgroups, probably reflecting the pathophysiology of the different hemodynamic lesions. This information should provide for a more rational approach to aortic valve replacement, at least in terms of early risk/benefit deliberations.

Entities:  

Mesh:

Year:  1985        PMID: 3974275

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Assessment of the Initial and Modified Parsonnet score in mortality prediction of the patients operated in the Sarajevo Heart center.

Authors:  Mirsad Kacila; Kaushal K Tiwari; Nermir Granov; Edin Omerbasić; Slavenka Straus
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

2.  Aortic valve replacement with combined myocardial revascularisation.

Authors:  M Jones; P M Schofield; N H Brooks; J F Dark; H Moussalli; A K Deiraniya; R A Lawson; A N Rahman
Journal:  Br Heart J       Date:  1989-07

3.  Cardio-aortic operation in octogenarians.

Authors:  M Ohashi; S Fukunaga; H Kawano; E Tayama; H Kashikie; H Akashi; T Kawara; A Ohryoji; S Aoyagi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

4.  [Risk of perioperative mortality and complications following biological aortic valve replacement in elderly patients: stented vs unstented bioprotheses].

Authors:  J Ennker; I Florath; U Rosendahl; S Bauer; E von Hodenberg; I C Ennker
Journal:  Z Kardiol       Date:  2001-12

Review 5.  How should we manage symptomatic aortic stenosis in the patient who is 80 or older?

Authors:  D C Sprigings; J C Forfar
Journal:  Br Heart J       Date:  1995-11

6.  Use and Outcomes of Acute Treatment Strategies in Patients with Severe Aortic Valve Stenosis.

Authors:  Sven M Piepenburg; Klaus Kaier; Christoph B Olivier; Wolfgang Bothe; Timo Heidt; Markus Jäckel; Alexander Peikert; Dennis Wolf; Manfred Zehender; Christoph Bode; Daniel Dürschmied; Constantin von Zur Mühlen; Peter Stachon
Journal:  Glob Heart       Date:  2021-12-27

7.  Aortic root surgery in septuagenarians: impact of different surgical techniques.

Authors:  Nawid Khaladj; Rainer Leyh; Malakh Shrestha; Sven Peterss; Axel Haverich; Christian Hagl
Journal:  J Cardiothorac Surg       Date:  2009-04-21       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.